Gavin R. Graff

2.7k total citations · 1 hit paper
50 papers, 1.9k citations indexed

About

Gavin R. Graff is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Gavin R. Graff has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 9 papers in Endocrine and Autonomic Systems. Recurrent topics in Gavin R. Graff's work include Cystic Fibrosis Research Advances (21 papers), Neuroscience of respiration and sleep (9 papers) and Neonatal Respiratory Health Research (7 papers). Gavin R. Graff is often cited by papers focused on Cystic Fibrosis Research Advances (21 papers), Neuroscience of respiration and sleep (9 papers) and Neonatal Respiratory Health Research (7 papers). Gavin R. Graff collaborates with scholars based in United States, Belgium and Myanmar. Gavin R. Graff's co-authors include Alexandros N. Vgontzas, Edward O. Bixler, Susan L. Calhoun, Fred G. Fedok, Vukmir Vlašić, Hung-Mo Lin, Duanping Liao, Antonio Vela‐Bueno, David Gozal and Richard Madsen and has published in prestigious journals such as Gastroenterology, American Journal of Respiratory and Critical Care Medicine and PEDIATRICS.

In The Last Decade

Gavin R. Graff

47 papers receiving 1.8k citations

Hit Papers

Sleep Disordered Breathing in Children in a General Popul... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gavin R. Graff United States 22 798 645 591 204 164 50 1.9k
Aviv Goldbart Israel 29 1.0k 1.3× 1.8k 2.7× 1.3k 2.1× 446 2.2× 141 0.9× 100 2.8k
Kim Van Hoorenbeeck Belgium 18 340 0.4× 597 0.9× 299 0.5× 65 0.3× 133 0.8× 92 1.4k
Siraj Wali Saudi Arabia 27 576 0.7× 604 0.9× 299 0.5× 280 1.4× 155 0.9× 112 1.9k
Alex Gileles‐Hillel Israel 24 434 0.5× 923 1.4× 545 0.9× 219 1.1× 75 0.5× 74 1.9k
Helena Martí-Soler Spain 26 778 1.0× 2.1k 3.3× 1.4k 2.4× 613 3.0× 250 1.5× 63 3.6k
Gary L. McPhail United States 17 462 0.6× 266 0.4× 235 0.4× 116 0.6× 131 0.8× 36 1.0k
Arnon Elizur Israel 35 665 0.8× 740 1.1× 105 0.2× 128 0.6× 773 4.7× 156 3.5k
Wendolyn S. Gozansky United States 22 239 0.3× 890 1.4× 311 0.5× 29 0.1× 120 0.7× 53 2.1k
Yolanda S. Castañeda United States 27 323 0.4× 223 0.3× 129 0.2× 106 0.5× 201 1.2× 55 2.5k
Francesca Orsini Australia 19 449 0.6× 233 0.4× 193 0.3× 52 0.3× 336 2.0× 55 1.6k

Countries citing papers authored by Gavin R. Graff

Since Specialization
Citations

This map shows the geographic impact of Gavin R. Graff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin R. Graff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin R. Graff more than expected).

Fields of papers citing papers by Gavin R. Graff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin R. Graff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin R. Graff. The network helps show where Gavin R. Graff may publish in the future.

Co-authorship network of co-authors of Gavin R. Graff

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin R. Graff. A scholar is included among the top collaborators of Gavin R. Graff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin R. Graff. Gavin R. Graff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayer-Hamblett, Nicole, George Retsch‐Bogart, Margaret Kloster, et al.. (2018). Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 198(9). 1177–1187. 73 indexed citations
2.
Sagel, Scott D., Umer Khan, Raksha Jain, et al.. (2018). Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 198(5). 639–647. 34 indexed citations
3.
Graff, Gavin R., et al.. (2018). Effect of topiramate on sweat chloride level while screening for cystic fibrosis. BMJ Case Reports. 2018. bcr–2018.
4.
Heubi, James E., David J. Schaeffer, Richard C. Ahrens, et al.. (2016). Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial. The Journal of Pediatrics. 176. 156–161.e1. 15 indexed citations
5.
Konstan, Michael W., Frank J. Accurso, Samya Z. Nasr, Richard C. Ahrens, & Gavin R. Graff. (2013). Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis. Clinical Investigation. 3(8). 723–729. 12 indexed citations
6.
Rosenfeld, Margaret, Julia Emerson, Sharon McNamara, et al.. (2010). Baseline Characteristics and Factors Associated With Nutritional and Pulmonary Status at Enrollment in the Cystic Fibrosis EPIC Observational Cohort. Pediatric Pulmonology. 45(9). 934–944. 41 indexed citations
7.
Graff, Gavin R., John McNamara, James A. Royall, Steven Caras, & K Forßmann. (2010). Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis. Clinical Drug Investigation. 30(6). 351–364. 22 indexed citations
10.
Wang, Guirong, Todd M. Umstead, Anatoly N. Mikerov, et al.. (2006). Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(5). L1052–L1063. 55 indexed citations
11.
Ramachandran, Venkataraman, et al.. (2004). Aortic hiatus gastric hernia. Pediatric Pulmonology. 37(3). 279–282.
12.
Graff, Gavin R., et al.. (2004). Nebulized Fentanyl for Palliation of Dyspnea in a Cystic Fibrosis Patient. Respiration. 71(6). 646–649. 21 indexed citations
14.
Graff, Gavin R., et al.. (2003). Montelukast pharmacokinetics in cystic fibrosis. The Journal of Pediatrics. 142(1). 53–56. 15 indexed citations
15.
Graff, Gavin R. & Jane L. Burns. (2002). Factors Affecting the Incidence of Stenotrophomonas maltophilia Isolation in Cystic Fibrosis. CHEST Journal. 121(6). 1754–1760. 60 indexed citations
16.
Graff, Gavin R.. (2001). Treatment of Recurrent Severe Hemoptysis in Cystic Fibrosis with Tranexamic Acid. Respiration. 68(1). 91–94. 28 indexed citations
17.
Bandla, Hari, Narong Simakajornboon, Gavin R. Graff, & David Gozal. (1999). Protein Kinase C Modulates Ventilatory Patterning in the Developing Rat. American Journal of Respiratory and Critical Care Medicine. 159(3). 968–973. 22 indexed citations
18.
Graff, Gavin R. & David Gozal. (1999). Cardiorespiratory Responses to Interleukin-1β in Adult Rats: Role of Nitric Oxide, Eicosanoids and Glucocorticoids. Archives of Physiology and Biochemistry. 107(2). 97–112. 22 indexed citations
19.
Gozal, David, Gavin R. Graff, Evelyne Gozal, & José E. Torres. (1998). Modulation of the hypoxic ventilatory response by Ca2+-dependent and Ca2+-independent protein kinase C in the dorsocaudal brainstem of conscious rats. Respiration Physiology. 112(3). 283–290. 15 indexed citations
20.
Graff, Gavin R.. (1997). Radiological Case of the Month. Archives of Pediatrics and Adolescent Medicine. 151(7). 737–737. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026